Aprogen pharmaceuticals,Inc.
KRX:003060.KS
805 (KRW) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||
Net Income
| -118,269.721 | 5,583.62 | 9,151.011 | 18,917.57 | -3,466.524 | -1,215.413 | -16,890.912 | -4,766.947 | 1,552.63 | -4,395.891 | -20,852.021 | -24,870.962 | -4,560.115 | -704.422 | -8,097.501 | -5,489.801 | -10,496.595 |
Depreciation & Amortization
| 21,397.603 | 2,403.985 | 2,071.853 | 1,932.047 | 1,660.645 | 1,466.134 | 1,675.444 | 1,427.595 | 1,599.479 | 1,386.836 | 789.66 | 947.814 | 969.592 | 409.549 | 574.546 | 653.642 | 639.369 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,227.582 | -1,312.959 | -468.872 | 15,909.426 | 17,208.781 | 2,843.962 | 3,502.073 | 0 | 438.962 | 9,030.851 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.029 | 111.587 | 157.752 | 464.023 | 259.842 | 566.736 | 54.612 | 0 | 111.762 | 44.335 |
Change In Working Capital
| -11,989.684 | 13,905.539 | -15,760.756 | -1,206.413 | -175.208 | 608.705 | -9,052.931 | -1,153.496 | 35.428 | -4,192.213 | 2,333.753 | 2,452.139 | -7,746.579 | -2,892.399 | -12,479.086 | -2,397.357 | -5,256.049 |
Accounts Receivables
| 1,124.134 | 69.05 | -631.641 | 1,161.42 | 1,349.041 | 1,255.048 | -7,174.225 | -1,008.892 | -370.349 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| -3,283.801 | -1,180.09 | -1,022.847 | -1,605.731 | -682.134 | 276.761 | -1,040.128 | -2,221.115 | -148.346 | -1,692.318 | 660.43 | -1,973.783 | 1,313.933 | -1,001.87 | 1,108.761 | -1,850.653 | -2,416.894 |
Accounts Payables
| -2,373.408 | 313.455 | -155.627 | 272.345 | -247.011 | 218.383 | -31.168 | -133.108 | 311.839 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -7,456.609 | 14,703.124 | -13,950.641 | -1,034.447 | -595.104 | 331.944 | -8,012.803 | 1,067.619 | 183.774 | -2,499.895 | 1,673.323 | 4,425.922 | -9,060.512 | -1,890.529 | -13,587.847 | -546.704 | -2,839.155 |
Other Non Cash Items
| 75,211.026 | 3,835.044 | -1,688.649 | -11,555.046 | 2,694.821 | 471.955 | 15,340.612 | 3,696.217 | -139.112 | 595.206 | -346.671 | 2,352.898 | 4,031.126 | -121.491 | 15,007.146 | 3,220.883 | 1,264.38 |
Operating Cash Flow
| -33,650.775 | 25,728.188 | -6,226.54 | 8,088.158 | 713.734 | 1,331.381 | -8,927.787 | 449.98 | 1,847.053 | -6,917.182 | -1,701.83 | -1,649.488 | -3,895.278 | 247.922 | -4,994.895 | -3,461.909 | -4,773.709 |
Investing Activities: | |||||||||||||||||
Investments In Property Plant And Equipment
| -28,395.973 | -1,545.199 | -1,442.128 | -1,421.49 | -2,421.048 | -2,244.313 | -2,649.146 | -2,820.297 | -7,534.722 | -2,195.127 | -9,701.397 | -1,101.789 | -4,615.95 | -12,439.764 | -699.663 | -590.294 | -2,083.698 |
Acquisitions Net
| 25,808.107 | 5,073.611 | -79.236 | 10,225 | 14,549.747 | -32,289.999 | -878.615 | -857.973 | 7,988.2 | -176.78 | 933.723 | 15,580.968 | -17,560 | 1,851.269 | -1,200 | -2,673.95 | -31.714 |
Purchases Of Investments
| -101,015 | -115,023 | -340,118 | -310,000 | -130,003.6 | -40,030 | -68,514.565 | -58,306.962 | -605.844 | -17,476.594 | -14,542 | -12,602.11 | -204 | -321 | -22,798.6 | -4,498.837 | -15,437.195 |
Sales Maturities Of Investments
| 21,324.99 | 135,219.5 | 415,048.406 | 229,267.891 | 86,999.962 | 31,565.49 | 32,579.109 | 25,402.974 | 5,932.504 | 11,008.835 | 10,576.274 | 10,580 | 160 | 560.25 | 435.98 | 7,717.586 | 2,742.133 |
Other Investing Activites
| 22,086.476 | -76,725.738 | -96,564.826 | -123,339.868 | -39,594.117 | -15,110.393 | 5,521.852 | 1,056.283 | 4,271.066 | -6,175.659 | 14,456.947 | -2,703.39 | 2,498.168 | 390.723 | -1,577.038 | 10,260.995 | -4,218.58 |
Investing Cash Flow
| -60,191.4 | -53,000.826 | -23,155.783 | -195,268.467 | -70,469.056 | -58,109.216 | -33,941.364 | -35,525.975 | 10,051.204 | -15,015.325 | 1,723.547 | 9,753.679 | -19,721.781 | -9,958.522 | -25,839.321 | 10,215.5 | -19,029.054 |
Financing Activities: | |||||||||||||||||
Debt Repayment
| -19,494.9 | -4,079.112 | -113.906 | -171.784 | -31,808.3 | -15,577.628 | -9,618.089 | -3,445.32 | -3,738.04 | -9,282.316 | -12,354.267 | -23,859.192 | -32,138.568 | -2,955.344 | -761.268 | -19,483.39 | -705 |
Common Stock Issued
| 61,104.871 | 0.244 | -0.955 | 235,376.175 | 106,068.203 | 70,075.56 | 273.15 | 851.053 | 506.494 | 9,953.633 | 8,192.596 | 12,720.514 | 20,998.377 | 19.574 | 3,008.016 | 11,010 | 1,944.239 |
Common Stock Repurchased
| -4,425.481 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -40.196 | 0 | 0 | 0 | 0 | 0 | -2.147 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 4,453.848 | 19,861.22 | -235.398 | -13,500.554 | 4,183.073 | 115.53 | 49,800.079 | 45,960.531 | -33.105 | 12,615.225 | 7,926.881 | 4,474.719 | 44,710.529 | 11,332.941 | 57,754.948 | 2,351.642 | 23,598.104 |
Financing Cash Flow
| 80,275.046 | 15,782.353 | -350.259 | 221,703.837 | 78,442.975 | 54,613.462 | 40,455.14 | 43,366.264 | -3,304.847 | 13,286.542 | 3,765.21 | -6,663.959 | 33,570.337 | 8,397.171 | 31,112.857 | -6,121.748 | 24,837.343 |
Other Information: | |||||||||||||||||
Effect Of Forex Changes On Cash
| 11.647 | 25.039 | 11.017 | -24.827 | -21.193 | 10.411 | -17.656 | -2.208 | 2.613 | 4.864 | -17.838 | -10.92 | -7.855 | 0.001 | 406.351 | -1,285.092 | 0 |
Net Change In Cash
| -13,555.483 | -11,465.247 | -29,721.565 | 34,498.7 | 8,666.46 | -2,153.963 | -2,431.667 | 8,288.062 | 8,596.022 | -8,641.101 | 3,769.09 | 1,429.313 | 9,945.423 | -1,313.428 | 684.992 | -653.249 | 1,034.58 |
Cash At End Of Period
| 10,053.36 | 23,608.843 | 35,074.09 | 64,795.655 | 30,296.955 | 21,630.495 | 23,784.457 | 26,216.124 | 17,928.062 | 9,332.04 | 17,973.141 | 14,204.052 | 12,774.739 | 2,829.316 | 2,966.283 | 2,281.291 | 2,934.54 |